Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.8916 | 37 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.80863 | 36 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.81072 | 36 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.79478 | 37 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.78129 | 36 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.89453 | 36 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.83697 | 34 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.0758 | 46 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.80461 | 36 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.82846 | 37 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.8229 | 36 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.81515 | 37 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.82736 | 36 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.79682 | 35 |